MORE►
acute pain
Lucas Rodriguez, CerSci [Photo: Skyler Fike]
Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal
by Quincy Preston | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
